Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

50.23
Delayed Data
As of Jun 30
 -0.03 / -0.06%
Today’s Change
48.01
Today|||52-Week Range
72.31
-23.48%
Year-to-Date
Bargain Buys: These 3 Biopharma Stocks Are All Down Big in 2016
Jun 30 / MotleyFool.com - Paid Partner Content
Impax (IPXL) Stock Declines on Deal to Buy Generic Products
Jun 22 / Zacks.com - Paid Partner Content
Teva Inches Closer to Completion of Allergan Generics Deal
Jun 28 / TheStreet.com - Paid Partner Content
Is Opko Health a Buy Now That Rayaldee Is Approved?
Jun 21 / MotleyFool.com - Paid Partner Content
Teva Pharmaceuticals (TEVA) Stock Climbs on Generic Products Sale
Jun 28 / TheStreet.com - Paid Partner Content
Why Is Impax Labs Tumbling 11.7% Today
Jun 21 / MotleyFool.com - Paid Partner Content
Teva's Cinqaero Gets Positive CHMP View, Decision in 2H16
Jun 27 / Zacks.com - Paid Partner Content
3 High-Growth Stocks You Don't Need to Babysit
Jun 17 / MotleyFool.com - Paid Partner Content
Allergan (AGN) Gets FDA Nod for Avycaz Label Expansion
Jun 24 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close50.26
Today’s open50.19
Day’s range49.76 - 50.45
Volume6,387,972
Average volume (3 months)6,013,573
Market cap$51.4B
Dividend yield2.71%
Data as of 06/30/2016

Growth & Valuation

Earnings growth (last year)-48.62%
Earnings growth (this year)-3.22%
Earnings growth (next 5 years)+6.45%
Revenue growth (last year)-3.25%
P/E ratio26.1
Price/Sales2.89
Price/Book1.72

Competitors

 Today’s
change
Today’s
% change
DEPODepomed Inc+0.20+1.03%
BGNEBeiGene Ltd-0.23-0.77%
OASMOasmia Pharmaceutica...+0.10+3.01%
VBLTVascular Biogenics L...+0.46+11.08%
Data as of 06/30/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$1.18
Annual revenue (last year)$19.6B
Annual profit (last year)$1.6B
Net profit margin8.09%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Erez Vigodman
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Tel Aviv

Forecasts

Partner Offers

Search for Jobs